Becton, Dickinson, & Co
Becton, Dickinson, & Co is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Becton, Dickinson, & Co.
Becton, Dickinson, & Co is a company.
Key people at Becton, Dickinson, & Co.
Becton, Dickinson & Co. (BD) is a global medical technology company that designs, manufactures, and sells medical devices, instrument systems, and reagents. It serves healthcare institutions, life science researchers, clinical laboratories, and patients worldwide by providing products that improve medical diagnostics, patient care, and infection prevention. BD’s offerings include syringes, needles, blood collection systems, diagnostic instruments, and surgical supplies, addressing critical healthcare challenges such as safe medication delivery and accurate diagnostics. The company has demonstrated steady growth and innovation momentum, expanding its product portfolio and global footprint over more than a century[1][3][6].
BD was founded in 1897 by Maxwell W. Becton and Fairleigh S. Dickinson, two salesmen who met during a sales trip and decided to partner in a medical supply business. They initially sold glass syringes and thermometers, later building their own manufacturing facility in East Rutherford, New Jersey. The company grew through acquisitions and innovation, including the 1949 patent of the Vacutainer blood collection system and the introduction of disposable syringes in the 1950s. Leadership passed to the founders’ sons in 1948, who expanded BD internationally and took the company public in 1962. BD’s evolution from a small partnership to a Fortune 500 medical technology leader reflects its adaptation to changing healthcare needs and markets[1][2][3][5][7].
BD rides the global trend toward safer, more efficient healthcare delivery and diagnostics, driven by increasing demand for infection control, chronic disease management, and laboratory automation. The timing aligns with heightened global health awareness and technological advances in medical devices and diagnostics. BD influences the ecosystem by setting quality and safety benchmarks, supporting healthcare infrastructure, and enabling research through life sciences tools. Its innovations contribute to reducing healthcare-associated infections and improving diagnostic accuracy, critical in both developed and emerging markets[6][7].
BD is positioned to continue leveraging its deep expertise and broad product base to address evolving healthcare challenges, including digital health integration and personalized medicine. Trends such as automation, data-driven diagnostics, and global health security will shape its innovation trajectory. The company’s influence is likely to grow as it expands in emerging markets and adapts to new regulatory and technological landscapes, maintaining its role as a key enabler of safer, more effective healthcare worldwide.
BD’s journey from a small medical supply partnership to a global medtech leader exemplifies how innovation, strategic growth, and commitment to healthcare safety can create lasting impact.
Key people at Becton, Dickinson, & Co.